GeneDx Holdings Corp vs Waste Management, Inc. — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.58B), while Waste Management, Inc. trades at $217.2 (market cap $86.51B). The key difference: Waste Management, Inc. is far larger — about 33.5× GeneDx Holdings Corp's market cap, and Waste Management, Inc. pays a 1.75% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | WM | |
|---|---|---|
Market Cap | $2.58B | $86.51B |
Sector | Technology | Industrials |
52-Week High | $167.51 | $246.51 |
52-Week Low | $34.51 | $196.77 |
Enterprise Value | $2.61B | $109.31B |
Dividend Yield | — | 1.75% |
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.
Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.
WM trades at $217.78, down 0.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed Q2 2026 earnings, beating EPS estimates at $2.02 versus $1.98 expected, but missed Q4 2025. Revenue grew to $25.20B in 2025, with a net income margin of 11.12%. Recent news highlights CEO transition and strong institutional buying, including a 26,113.1% position increase by California State Teachers Retirement System in Q2 2026.
Outlook remains positive with a consensus price target of $263.43, implying 21% upside, supported by steady waste demand and sustainability investments. Risks include high debt levels, with a debt-to-asset ratio of 49.97% in 2025, and valuation concerns at a P/E of 30.8. The stock offers a dividend yield from recent payouts, but investors face execution risks amid leadership changes and economic sensitivity.
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →